BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29728952)

  • 1. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.
    Narang A; Blair JE; Patel MB; Mor-Avi V; Fedson SE; Uriel N; Lang RM; Patel AR
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1607-1617. PubMed ID: 29728952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.
    Husain N; Watanabe K; Berhane H; Gupta A; Markl M; Rigsby CK; Robinson JD
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):135. PubMed ID: 34809650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac
    Shrestha UM; Sciammarella M; Pampaloni MH; Botvinick EH; Gullberg GT; DeMarco T; Seo Y
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1461-1472. PubMed ID: 33123937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Detection of Cardiac Allograft Vasculopathy by Stress Exercise Echocardiographic Assessment of Myocardial Deformation.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Tolbod LP; Harms HJ; Bouchelouche K; Hoff C; Frøkiær J; Poulsen SH
    J Am Soc Echocardiogr; 2016 May; 29(5):480-90. PubMed ID: 26898523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Global Myocardial Work Efficiency Correlates with Coronary Vasculopathy in Pediatric Heart Transplant Patients.
    Pradhan S; Mullikin A; Zang H; Ollberding NJ; Stark S; Hill GD; Chin C; Tretter JT
    Pediatr Cardiol; 2022 Mar; 43(3):515-524. PubMed ID: 34651198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation.
    Mirelis JG; García-Pavía P; Cavero MA; González-López E; Echavarria-Pinto M; Pastrana M; Segovia J; Oteo JF; Alonso-Pulpón L; Escaned J
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):571-8. PubMed ID: 25522835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.
    Bravo PE; Bergmark BA; Vita T; Taqueti VR; Gupta A; Seidelmann S; Christensen TE; Osborne MT; Shah NR; Ghosh N; Hainer J; Bibbo CF; Harrington M; Costantino F; Mehra MR; Dorbala S; Blankstein R; Desai A; Stevenson L; Givertz MM; Di Carli MF
    Eur Heart J; 2018 Jan; 39(4):316-323. PubMed ID: 29236988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy.
    van Heeswijk RB; Bastiaansen JAM; Iglesias JF; Degrauwe S; Rotman S; Barras JL; Regamey J; Lauriers N; Tozzi P; Yerly J; Ginami G; Stuber M; Hullin R
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):533-542. PubMed ID: 31724114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.
    Coelho-Filho OR; Shah R; Lavagnoli CFR; Barros JC; Neilan TG; Murthy VL; de Oliveira PPM; Souza JRM; de Oliveira Severino ESB; de Souza Vilarinho KA; da Mota Silveira Filho L; Garcia J; Semigran MJ; Coelho OR; Jerosch-Herold M; Petrucci O
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):15-24. PubMed ID: 27437924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Myocardial Blood Flow for Post-transplant Surveillance and Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
    Feher A; Miller EJ
    Curr Cardiol Rep; 2022 Dec; 24(12):1865-1871. PubMed ID: 36279035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Utility of Right Ventricular Free Wall Strain in Low Risk Patients After Orthotopic Heart Transplantation.
    Barakat AF; Sperry BW; Starling RC; Mentias A; Popovic ZB; Griffin BP; Desai MY
    Am J Cardiol; 2017 Jun; 119(11):1890-1896. PubMed ID: 28390683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.
    DeSa TB; Abbasi MA; Blaisdell JA; Lin K; Collins JD; Carr JC; Markl M
    Clin Imaging; 2020 May; 61():62-68. PubMed ID: 31981959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy.
    Sade LE; Eroğlu S; Yüce D; Bircan A; Pirat B; Sezgin A; Aydınalp A; Müderrisoğlu H
    J Am Soc Echocardiogr; 2014 May; 27(5):531-9. PubMed ID: 24613313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac PET Myocardial Blood Flow Quantification Assessment of Early Cardiac Allograft Vasculopathy.
    Chih S; Tavoosi A; Nair V; Chong AY; Džavík V; Aleksova N; So DY; deKemp RA; Amara I; Wells GA; Bernick J; Overgaard CB; Celiker-Guler E; Mielniczuk LM; Stadnick E; McGuinty C; Ross HJ; Beanlands RSB
    JACC Cardiovasc Imaging; 2024 Jun; 17(6):642-655. PubMed ID: 37999656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy.
    Miller CA; Sarma J; Naish JH; Yonan N; Williams SG; Shaw SM; Clark D; Pearce K; Stout M; Potluri R; Borg A; Coutts G; Chowdhary S; McCann GP; Parker GJ; Ray SG; Schmitt M
    J Am Coll Cardiol; 2014 Mar; 63(8):799-808. PubMed ID: 24355800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.